What the evidence says about creatine and thinking
The trials are small, short and mostly about muscle. The two meta-analyses that pool the cognitive ones do not agree about who benefits, and that disagreement is the useful part.
Reviewed — a delegated second read (D-295, D-356)
Reviewed on 2026-10-20 against the content and evidence rules: every sentence was read against them, and at least one citation in each unit that cites was re-resolved against the raw record it names. The owner delegated the read on 2026-10-20 and the Lead signed on his behalf (D-356, by the method of D-295) — it is a delegated review, not the owner's own reading of the page. That read held this note at first: it was rewritten and passed a second read by delegation (D-356) on 2026-10-21, against the same rules, with every citation in it re-resolved against the raw record it names. This note was last reviewed on 2026-10-21. Every claim in it carries an evidence grade, and the sources are listed at the end.
Two meta-analyses report a memory effect, and they do not agree on whom it belongs to. One placed it in adults aged 66 to 76 and found nothing in people aged 11 to 31 [1]. The other did not split memory by age. On attention time it found an effect in adults aged 18 to 60 and none in its trials of people over 60; split by health instead, it found none in healthy participants (five trials) and an effect in patients (three) [2]. Every result is a score on a test task, measured over days to weeks.
What is actually being asked
Creatine is not exotic. It is found mainly in red meat and seafood, your body also makes it, and about 95 per cent of it sits in skeletal muscle, with small amounts in the brain [3]. Its role in how the brain handles energy is the reason given for testing it on memory [1] — and a mechanism is where a question starts, never where it ends.
The question a supplement page should be asked is narrow: in people like me, eating what I eat, does taking this change how I perform on a task that resembles something I care about? Read that way, the position stand on creatine is mostly about exercise and sport [3], and the cognitive trials are a small set: one review found ten trials of memory in healthy people that met its criteria, and pooled eight of them [1].
What the two meta-analyses found
Prokopidis and colleagues (2023) pooled eight randomised trials of creatine and memory in healthy people and reported a small overall benefit, a standardised mean difference of 0.29. Its own subgroup analysis placed that effect in older adults, aged 66 to 76 (0.88), and found none in people aged 11 to 31 (0.03) [1]. A letter to the journal has since argued that the analysis double-counted participants and that this produced false-positive findings [4].
Xu and colleagues (2024) pooled 16 randomised trials — 492 adults aged 20.8 to 76.4, healthy people and patients with specific diseases together — and reported an effect on memory of 0.31, rating their certainty for it moderate, with low-certainty signals on attention time and processing-speed time and no significant change in overall cognitive function or executive function [2]. They did not split memory by age. On attention time, which they did split that way, three trials of people over 60 showed no significant effect and five trials of adults aged 18 to 60 showed one; split by health instead, the same table found none in healthy participants (five trials) and an effect in patients (three) [2]. The paper carries a published corrigendum and a published commentary [2]. A pooled estimate inherits the weaknesses of what it pools; it does not launder them.
Put side by side, the two do not tell one story. One finds the memory effect in older adults and nothing in the young; the other finds its only age difference, on a different outcome, in adults under 60 and nothing over it. Prokopidis also excluded vegetarians and vegans from its pool [1], so its result says nothing about people who eat no meat. The honest summary is that a memory effect appears in pooled trials and that who it belongs to is not settled.
What the trials measured, and what they did not
Every cognitive number on this page comes from a test task: recall a list, respond to a cue, hold a sequence. Those tasks are chosen because they are stable and repeatable, not because they resemble a Tuesday afternoon. The outcomes the two meta-analyses report are memory, attention, processing speed, executive function and overall cognitive function [1][2]; neither reports whether anyone wrote a better report, studied more effectively or felt clearer.
So the correct summary of a positive result is: on this task, in this group, over these weeks, the supplemented group scored better than the placebo group. Anything beyond that sentence is added by the person quoting it.
Safety, briefly and without softening
The International Society of Sports Nutrition's 2017 position stand reviewed the safety literature and found no evidence of harm from creatine monohydrate at recommended doses in healthy people. The only side effect it found consistently reported is weight gain [3].
Two flags stay attached. Anyone with kidney disease should raise it with a clinician before starting, and this site is written for adults only. Nothing on this page is medical advice, and nothing here diagnoses, treats or prevents any condition.
How this fits the rest of the product
Fuel opens on diet, not on supplements, and the order is deliberate: sleep and recovery, then nutrition adequacy, then physical activity, then learning, training and environment, and only then targeted supplementation, where justified. Nothing in the seven-day protocol the Snapshot produces requires a purchase, a device, an app or a supplement, and that stays true.
If you came here from a video promising a step change, the honest summary is shorter than the video: a memory effect in some pooled trials, disagreement about whom it belongs to, and nothing measured outside a test task.
Every claim above, with its grade and its weakest link
A grade belongs to one claim, in one population, for one preparation — never to a compound, a technique or an article. The weakest link is the part of the chain between the evidence and the thing you would actually do that is doing the least work.
| Claim | In whom | Grade | Weakest link |
|---|---|---|---|
| Creatine monohydrate supplementation improves memory task scores in older adults | Healthy older adults, 66–76 | Evidence grade C: Early research suggests | Study quality — one subgroup of a pool of eight small trials (I² 83 % in this band), a published letter argues the analysis double-counted participants, and the other meta-analysis found no effect in its over-60 trials on the one outcome it split by age |
| Creatine monohydrate supplementation improves memory task scores in young people | Healthy people aged 11–31 | Evidence grade D: Human evidence insufficient | Population match — the band runs from 11 to 31, so schoolchildren and thirty-year-olds share one flat estimate (0.03, 95 % CI −0.14 to 0.20); read it as evidence against an effect in that band, not as an open question |
| Creatine monohydrate supplementation improves memory task scores in adults, healthy or not | Adults 20.8–76.4, healthy people and patients pooled together | Evidence grade C: Early research suggests | Population match — healthy adults and patients with specific diseases are pooled in one estimate, so the effect belongs to no particular group |
| Creatine monohydrate supplementation shortens response times on attention tasks in adults aged 18 to 60 | Adults 18–60, in five trials of a pool that mixes healthy people and patients | Evidence grade C: Early research suggests | Study quality — a subgroup of five small trials, the paper rates its own certainty on attention as low, and split by health the same table finds the effect in patients, not in healthy people |
| Creatine monohydrate supplementation shortens response times on attention tasks in healthy adults | Healthy adults, in five trials | Evidence grade D: Human evidence insufficient | Study quality — the pooled estimate is not significant (SMD −0.18, 95 % CI −0.62 to 0.27); read it as no shown effect in healthy people, not as a small one |
| Creatine monohydrate at recommended doses shows no evidence of harm in healthy people | Healthy adults without kidney disease | Evidence grade C: Early research suggests | Population match — the safety literature behind the position stand is overwhelmingly in athletes, which is not the base this claim is usually quoted about |
Everything this note is built on
- Prokopidis K, Giannos P, Triantafyllidis KK, Kechagias KS, Forbes SC, Candow DG (2023). Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews 81:416–427.meta-analysis · link checked 2026-10-21Fuel Creatine monohydrate
- Xu C, Bi S, Zhang W, Luo L (2024). The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition 11:1424972.meta-analysis · link checked 2026-10-21Fuel Creatine monohydrate
- Kreider RB et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport and medicine. JISSN 14:18.position stand · link checked 2026-10-21Fuel Creatine monohydrate
- Eckert I, Pascher E (2023). Letter to the Editor: Double-counting due to inadequate statistics leads to false-positive findings in “Effects of creatine supplementation on memory in healthy individuals”. Nutrition Reviews 81:1495–1496.letter · link checked 2026-10-21
And the ones that are planned and not written yet.
Free, scored in your browser, and no account needed.